Multispecific Bispecific Trispecific Antibodies Market Opportunity and Clinical Development Insight Delhi, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Delhi, India:  In recent years, the palliative care and the treatment of diseases have seen a revolution with the arrival of more targeted therapies and...

Cytovia Therapeutics Expands Leadership Team Jason Aryeh elected to Board of DirectorsElizabeth Schwarzbach, PhD and Boris Reznik, PhD join Strategic Advisory BoardElysa Mantel appointed as Vice President, General Counsel and Corporate Secretary...

Stanley R. Frankel, MD, FACP joins Cytovia Therapeutics as Chief Medical Officer CAMBRIDGE, Mass. and AVENTURA, Fla., April 28, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen...

Cytovia Therapeutics Files New Patents for its Natural Killer Cell Engager Multifunctional Antibodies (FLEX-NK®) for the Treatment of Hematological and Solid Tumors CAMBRIDGE, Mass. and AVENTURA, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen...